JP2020519673A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020519673A5 JP2020519673A5 JP2019563219A JP2019563219A JP2020519673A5 JP 2020519673 A5 JP2020519673 A5 JP 2020519673A5 JP 2019563219 A JP2019563219 A JP 2019563219A JP 2019563219 A JP2019563219 A JP 2019563219A JP 2020519673 A5 JP2020519673 A5 JP 2020519673A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- salt
- seq
- complex
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023040807A JP7705160B2 (ja) | 2017-05-14 | 2023-03-15 | 生物活性複合体の調製 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1707715.7 | 2017-05-14 | ||
| GBGB1707715.7A GB201707715D0 (en) | 2017-05-14 | 2017-05-14 | Preperation of biologically active complexes |
| PCT/EP2018/062396 WO2018210759A1 (en) | 2017-05-14 | 2018-05-14 | Preparation of biologically active complexes |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023040807A Division JP7705160B2 (ja) | 2017-05-14 | 2023-03-15 | 生物活性複合体の調製 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020519673A JP2020519673A (ja) | 2020-07-02 |
| JP2020519673A5 true JP2020519673A5 (enExample) | 2021-07-26 |
| JP7672122B2 JP7672122B2 (ja) | 2025-05-07 |
Family
ID=59201543
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019563219A Active JP7672122B2 (ja) | 2017-05-14 | 2018-05-14 | 生物活性複合体の調製 |
| JP2023040807A Active JP7705160B2 (ja) | 2017-05-14 | 2023-03-15 | 生物活性複合体の調製 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023040807A Active JP7705160B2 (ja) | 2017-05-14 | 2023-03-15 | 生物活性複合体の調製 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20200140481A1 (enExample) |
| EP (2) | EP3811967B1 (enExample) |
| JP (2) | JP7672122B2 (enExample) |
| KR (2) | KR20260021814A (enExample) |
| CN (2) | CN110650746B (enExample) |
| AU (1) | AU2018269304B2 (enExample) |
| CA (1) | CA3063285A1 (enExample) |
| DK (2) | DK3811967T5 (enExample) |
| ES (2) | ES2861252T3 (enExample) |
| FI (1) | FI3811967T3 (enExample) |
| GB (1) | GB201707715D0 (enExample) |
| PL (2) | PL3811967T3 (enExample) |
| WO (1) | WO2018210759A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201621752D0 (en) * | 2016-12-20 | 2017-02-01 | Hamlet Pharma Ab | Therapeutically active complexes |
| GB201707715D0 (en) * | 2017-05-14 | 2017-06-28 | Hamlet Pharma Ab | Preperation of biologically active complexes |
| WO2019243547A1 (en) * | 2018-06-20 | 2019-12-26 | Hamlet Pharma Ab | Therapeutically active complexes |
| GB2574845A (en) * | 2018-06-20 | 2019-12-25 | Hamlet Pharma Ab | Therapeutically active complexes |
| US20220323391A1 (en) * | 2019-08-20 | 2022-10-13 | Hamlet Pharma Ab | Combination of a chemotherapeutic agent and alpha-lactoglubulin-oleic acid complex for cancer therapy |
| GB202015836D0 (en) | 2020-10-06 | 2020-11-18 | Hamlet Pharma Ab | Compositions |
| JP2025534430A (ja) | 2022-10-03 | 2025-10-15 | リネイン ファルマ アーベー | 癌の治療または予防に使用するためのα－ラクトアルブミンおよび脂肪酸または脂質を含む複合体 |
| GB202303177D0 (en) | 2023-03-03 | 2023-04-19 | Linnane Pharma Ab | Method of predicting response to treatment |
| WO2025186107A1 (en) | 2024-03-04 | 2025-09-12 | Linnane Pharma Ab | Therapy |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005024044A2 (en) * | 2003-09-05 | 2005-03-17 | Gtc Biotherapeutics, Inc. | Method for the production of fusion proteins in transgenic mammal milk |
| WO2010079362A1 (en) | 2009-01-09 | 2010-07-15 | Hamlet Pharma Ab | Complex and production process |
| WO2010131237A1 (en) | 2009-05-13 | 2010-11-18 | Agriculture And Food Development Authority (Teagasc) | A process for producing a biologically active globular protein complex |
| GB0908279D0 (en) | 2009-05-14 | 2009-06-24 | Enovate Systems Ltd | Subsea winch |
| WO2012069836A2 (en) * | 2010-11-24 | 2012-05-31 | Hamlet Pharma Ab | Biologically active complex and its preparation |
| HUE038910T2 (hu) | 2012-08-09 | 2018-12-28 | Hamlet Pharma Ab | Profilaktikus és gyógytáp terápia |
| GB201621752D0 (en) * | 2016-12-20 | 2017-02-01 | Hamlet Pharma Ab | Therapeutically active complexes |
| GB201707715D0 (en) | 2017-05-14 | 2017-06-28 | Hamlet Pharma Ab | Preperation of biologically active complexes |
-
2017
- 2017-05-14 GB GBGB1707715.7A patent/GB201707715D0/en not_active Ceased
-
2018
- 2018-05-14 WO PCT/EP2018/062396 patent/WO2018210759A1/en not_active Ceased
- 2018-05-14 KR KR1020267002686A patent/KR20260021814A/ko active Pending
- 2018-05-14 DK DK20208669.0T patent/DK3811967T5/da active
- 2018-05-14 US US16/612,272 patent/US20200140481A1/en not_active Abandoned
- 2018-05-14 CN CN201880032057.6A patent/CN110650746B/zh active Active
- 2018-05-14 CN CN202411849059.8A patent/CN119700935A/zh active Pending
- 2018-05-14 ES ES18729327T patent/ES2861252T3/es active Active
- 2018-05-14 DK DK18729327.9T patent/DK3618848T3/da active
- 2018-05-14 EP EP20208669.0A patent/EP3811967B1/en active Active
- 2018-05-14 KR KR1020197037015A patent/KR20200015557A/ko not_active Ceased
- 2018-05-14 CA CA3063285A patent/CA3063285A1/en active Pending
- 2018-05-14 EP EP18729327.9A patent/EP3618848B1/en active Active
- 2018-05-14 FI FIEP20208669.0T patent/FI3811967T3/fi active
- 2018-05-14 PL PL20208669.0T patent/PL3811967T3/pl unknown
- 2018-05-14 ES ES20208669T patent/ES2973290T3/es active Active
- 2018-05-14 JP JP2019563219A patent/JP7672122B2/ja active Active
- 2018-05-14 AU AU2018269304A patent/AU2018269304B2/en active Active
- 2018-05-14 PL PL18729327T patent/PL3618848T3/pl unknown
-
2021
- 2021-01-12 US US17/146,588 patent/US12331073B2/en active Active
-
2023
- 2023-03-15 JP JP2023040807A patent/JP7705160B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020519673A5 (enExample) | ||
| FI3811967T3 (fi) | Biologisesti aktiivisten kompleksien valmistus | |
| US10464968B2 (en) | Method for producing a composition for treating a tooth lesion | |
| AU609899B2 (en) | Plasma and recombinant protein formulations in low ionic strength media | |
| JP2019194251A5 (enExample) | ||
| EP0314095A1 (en) | Plasma and recombinant protein formulation in high ionic strength media | |
| FI3510049T3 (fi) | Happo alfa-glukosidaasin muunnoksia ja niiden käyttöjä | |
| JP2017529326A5 (enExample) | ||
| CN104045717A (zh) | 一种肿瘤血管阻断剂多肽、基因、表达载体及其应用 | |
| JP2019533722A5 (enExample) | ||
| CN106459140A (zh) | 用于纯化免疫球蛋白的方法 | |
| JPH0925241A (ja) | Ｈｇｆ凍結乾燥製剤 | |
| US10493133B2 (en) | Method for preparing highly concentrated fibrinogen solution and method for preparing fibrin sealant by using thereof | |
| Vogel et al. | Complement depletion with humanised cobra venom factor: efficacy in preclinical models of vascular diseases | |
| TW201215414A (en) | Lyophilized formulation of recombinant human bone morphogenetic protein-2 | |
| JP2018502860A5 (enExample) | ||
| JP2003501479A (ja) | 薬 剤 | |
| CN103153333A (zh) | 补体因子h的纯化方法 | |
| CN102441172B (zh) | 高纯度凝血酶原复合物制品冷冻干燥稳定剂 | |
| JP6781974B2 (ja) | アドレノメデュリン凍結乾燥製剤の製造方法 | |
| JP2020097571A (ja) | ヴァン・ウィルブランド因子の新規な使用 | |
| WO2009151327A1 (en) | Block co-polypeptide and hydrogels made thereof | |
| CN114787185B (zh) | 一种凝血因子ⅷ中间品的冻存方法 | |
| JP2019519466A5 (enExample) | ||
| CN103041380B (zh) | 人抗凝血酶制剂干热处理过程中的稳定剂 |